When is crossover desirable in cancer drug trials and when is it…

When is crossover desirable in cancer drug trials and when is it…

This was noted in an Agency for Healthcare Research & Quality (AHRQ) report on sipuleucel-T [ … Search ADSPubMed11Agency for Healthcare Research and Quality. Outcomes of sipuleucel-T…

3
Like
Save

Comments

Write a comment

*